{
  "id": 34,
  "task_text": "[Vaccinology][Comparative-Analysis] Compare booster-dose rationale presented in the ACP and MDPI documents.",
  "category": "Vaccinology",
  "task_type": "Comparative-Analysis",
  "agent_classification": "Multi-Tool",
  "gold_end_state": {
    "summary": "ACP discusses boosters in the context of waning immunity and expanding coverage strategies, while MDPI frames boosters based on immunogenicity data, variant-driven immune escape, and trial/post-marketing evidence; both support booster use when evidence shows improved protection or in response to variant threats.",
    "quiz": [
      {
        "question": "Which evidence base is emphasized by MDPI for justifying boosters?",
        "options": [
          "Immunogenicity and real-world effectiveness data",
          "Historical vaccine pricing",
          "Media coverage only",
          "Cold-chain logistics"
        ],
        "answer": "Immunogenicity and real-world effectiveness data"
      }
    ]
  },
  "oracle_plan": [
    {
      "tool_name": "content_extractor",
      "arguments": {
        "text": "acp_covid19_vaccination.txt"
      }
    },
    {
      "tool_name": "content_extractor",
      "arguments": {
        "text": "mdpi_covid19_vaccine.txt"
      }
    },
    {
      "tool_name": "quiz_generator",
      "arguments": {
        "text": "Booster rationale comparison"
      }
    }
  ]
}